Pharmacy advocates make their voices heard on Capitol Hill
NACDS stated the advocacy effort shows the industry's shared goal to ensure lawmakers recognize the value of pharmacies to patients and healthcare.
NACDS stated the advocacy effort shows the industry's shared goal to ensure lawmakers recognize the value of pharmacies to patients and healthcare.
“While these reforms begin to address one of the most significant challenges pharmacists face under Medicare, they represent only part of what’s needed,” says APhA CEO.
The reforms "are integral to reducing people's drug costs and keeping pharmacy care within reach, and they must be implemented swiftly, effectively, and as intended."
“These bipartisan reforms represent a major step towards lower costs, better care and less red tape in our pharmacies.”
House action now needed to send landmark PBM reforms to President Trump's desk.
The U.S. Department of Labor has proposed a regulation that represents the most substantial federal PBM reform in many years.
Pharmacy organizations are urging lawmakers to act quickly and send the legislation to the White House.
Meaningful reform must address three key issues: transparency, fair pharmacy reimbursement, and ending PBM spread pricing.
The case revolves around a state law (Act 624) passed earlier this year blocking PBMs in Arkansas from also operating pharmacies in the state.
Community Access National Network (CANN) urges lawmakers to prioritize patients over profits in 340B reforms.
Citing polling that found 97% of Americans want steps to reduce pharmacy closures, NACDS urged Congress and the Administration to reject PBM proposals and pass enforceable reforms.
Express Scripts’ court fight with Martella Pharmacies underscores increasing scrutiny of PBMs and concerns over rural pharmacy closures.
Bupathi offers timely insights on the evolving pharmacy-PBM dynamic.
National and state pharmacy groups emphasize the need for state control to regulate PBMs and protect local pharmacies, patients, and health plans.
The Swiss drugmaker is in active discussions with the U.S. government regarding a plan that could eliminate middlemen, such as pharmacy benefit managers (PBMs).